• Revenue up 33.5% to $627.2 million
• EBITDA increased significantly to $95.2 million
• Profit after tax of $4.8 million, a turnaround from prior year loss

Integral Diagnostics Ltd (ASX:IDX) has reported its financial results for the year ended 30 June 2025. The company reported revenue of $627.2 million, up 33.5% from the prior year. Earnings Before Interest, Tax, Depreciation and Amortisation (EBITDA) increased significantly to $95.2 million, compared to $11.4 million in the previous year. Profit from ordinary activities after tax was $4.8 million, a turnaround from the prior year loss of $60.7 million. The company declared a final dividend of 4.0 cents per share, fully franked, to be paid on 3 October 2025. Integral Diagnostics also gained control of 25 entities effective 20 December 2024, expanding its diagnostic imaging network across Australia and New Zealand. The company's brands include Lake Imaging, Capital Radiology, Future Medical Imaging Group, The X-ray Group, Imaging Queensland, South Coast Radiology, Radiology Tasmania, Apex Radiology, Fowler Simmons Radiology, and several brands in New Zealand.